Pliant Therapeutics (FRA:9PT) 3-Year Book Growth Rate : -0.20% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Pliant Therapeutics 3-Year Book Growth Rate?

Pliant Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was €6.67.

During the past 12 months, Pliant Therapeutics's average Book Value per Share Growth Rate was -23.90% per year. During the past 3 years, the average Book Value per Share Growth Rate was -0.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 6 years, the highest 3-Year average Book Value per Share Growth Rate of Pliant Therapeutics was -0.20% per year. The lowest was -0.20% per year. And the median was -0.20% per year.

Competitive Comparison of Pliant Therapeutics's 3-Year Book Growth Rate

For the Biotechnology subindustry, Pliant Therapeutics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pliant Therapeutics's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pliant Therapeutics's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Pliant Therapeutics's 3-Year Book Growth Rate falls into.

Pliant Therapeutics 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Pliant Therapeutics (FRA:9PT) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Pliant Therapeutics 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Pliant Therapeutics's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Pliant Therapeutics (FRA:9PT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pliant Therapeutics Inc (FRA:9PT) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

PLRX:USA

Address

260 Littlefield Avenue, South San Francisco, CA, USA, 94080

Website

https://www.pliantrx.com

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Pliant Therapeutics (FRA:9PT) Headlines

No Headlines